Anti-inflammatory drugs may improve treatment of abnormal maternal inflammation

New research out of Queen's University has shown that anti-inflammatory drugs could be beneficial in the treatment of abnormal maternal inflammation during pregnancy, a condition that can cause serious diseases like pre-eclampsia and can lead to small babies.

Professor Charles Graham (Biomedical and Molecular Sciences) worked on the project along with lead author Tiziana Cotechini (PhD student, Biomedical and Molecular Sciences) and co-authors Maria Komisarenko, Arissa Sperou, Shannyn Macdonald-Goodfellow and Michael A. Adams.

"Babies who are born too small are referred to as growth restricted," says Professor Graham. "These are at an increased risk of suffering from diabetes and heart disease in their adult lives. Many of these growth-restricted babies are born to women suffering from pre-eclampsia, a disease often associated with excessive maternal inflammation during pregnancy."

According to the research, there are currently no effective treatments to prevent or pre-eclampsia as doctors do not fully understand the factors that cause these diseases.

"We believe that excessive maternal inflammation during pregnancy restricts blood flow to the placenta which leads to and pre-eclampsia," says Professor Graham.

This new research shows that abnormal maternal inflammation may be an important factor that causes certain complications of pregnancy. The research group will continue investigating the role of in diseases of pregnancy and how anti-inflammatory drugs may be a beneficial treatment option.

More information: The research was funded by the Canadian Institutes of Health Research and was published in the Journal of Experimental Medicine: jem.rupress.org/content/early/… em.20130295.abstract

add to favorites email to friend print save as pdf

Related Stories

Fish oil found to help serious pregnancy complications

Jul 29, 2013

Taking fish oil during pregnancy could limit the effects of serious complications such as gestational diabetes, pre-eclampsia and miscarriage as well as enhancing fetal growth, according to researchers at ...

Recommended for you

A better biomonitor for children with asthma

Dec 10, 2014

For the firefighters and rescue workers conducting the rescue and cleanup operations at Ground Zero from September 2001 to May 2002, exposure to hazardous airborne particles led to a disturbing "WTC cough"—obstructed ...

New insight into risk of Ankylosing Spondylitis

Dec 09, 2014

Scientists at the University of Southampton have discovered variations in an enzyme belonging to the immune system that leaves individuals susceptible to Ankylosing Spondylitis.

Novel approach to treating asthma: Neutralize the trigger

Dec 03, 2014

Current asthma treatments can alleviate wheezing, coughing and other symptoms felt by millions of Americans every year, but they don't get to the root cause of the condition. Now, for the first time, scientists ...

Inflammatory discovery sheds new light on skin disease

Dec 02, 2014

Inflammatory skin diseases such as psoriasis may result from abnormal activation of cell death pathways previously believed to suppress inflammation, a surprise finding that could help to develop new ways ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.